Your browser doesn't support javascript.
loading
Improved survival prediction for oropharyngeal cancer beyond TNMv8.
Price, J M; West, C M; Mistry, H B; Betts, G; Bishop, P; Kennedy, J; Dixon, L; Homer, J J; Garcez, K P; Lee, L W; McPartlin, A; Sykes, A J; Thomson, D J.
Afiliación
  • Price JM; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • West CM; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Mistry HB; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Betts G; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Bishop P; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Kennedy J; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Dixon L; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Homer JJ; Department of Head & Neck Surgery, Manchester University NHS Foundation Trust, Manchester, UK.
  • Garcez KP; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Lee LW; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • McPartlin A; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Sykes AJ; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Thomson DJ; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: david.thomson2@nhs.net.
Oral Oncol ; 115: 105140, 2021 04.
Article en En | MEDLINE | ID: mdl-33548862
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido